102 related articles for article (PubMed ID: 8199079)
1. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix.
Konishi I; Ishikawa Y; Wang SY; Wang DP; Koshiyama M; Mandai M; Komatsu T; Yamamoto S; Mori T
Br J Obstet Gynaecol; 1994 Apr; 101(4):325-9. PubMed ID: 8199079
[TBL] [Abstract][Full Text] [Related]
2. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.
Smedts F; Ramaekers F; Leube RE; Keijser K; Link M; Vooijs P
Am J Pathol; 1993 Feb; 142(2):403-12. PubMed ID: 7679549
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions.
Xynos FP; Klos DJ; Hamilton PD; Schuette V; Fernandez-Pol JA
Anticancer Res; 1992; 12(4):1115-20. PubMed ID: 1323947
[TBL] [Abstract][Full Text] [Related]
4. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
[TBL] [Abstract][Full Text] [Related]
5. Lectin binding to normal, dysplastic, and neoplastic cervical epithelium.
Bychkov V; Toto PD
Am J Clin Pathol; 1986 May; 85(5):542-7. PubMed ID: 3706196
[TBL] [Abstract][Full Text] [Related]
6. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
[TBL] [Abstract][Full Text] [Related]
7. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-alpha in the normal cervix and in the benign and malignant lesions of the uterine cervix.
Eustace D
Br J Obstet Gynaecol; 1995 Jan; 102(1):83-4. PubMed ID: 7833331
[No Abstract] [Full Text] [Related]
9. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A
Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126
[TBL] [Abstract][Full Text] [Related]
10. The prognosis significance of TGF-β1 and ER protein in cervical adenocarcinoma patients with stage Ib~IIa.
Fan DM; Tian XY; Wang RF; Yu JJ
Tumour Biol; 2014 Nov; 35(11):11237-42. PubMed ID: 25113249
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix.
Inki P; Stenbäck F; Grenman S; Jalkanen M
J Pathol; 1994 Apr; 172(4):349-55. PubMed ID: 8207616
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cytokeratin marker CAM 5.2 in cervical neoplasia.
Raju GC
Histopathology; 1988 Apr; 12(4):437-43. PubMed ID: 2453439
[TBL] [Abstract][Full Text] [Related]
13. [The expression of cytokeratin No. 17 in squamous cell cancer of the cervix uteri: an immunohistochemical study of 19 cases].
Petrov SV; Raĭkhlin NT
Vopr Onkol; 1992; 38(7):797-805. PubMed ID: 1284457
[TBL] [Abstract][Full Text] [Related]
14. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression.
Lee CS; Redshaw A; Boag G
Aust N Z J Surg; 1996 Jul; 66(7):464-8. PubMed ID: 8678876
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
16. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.
Brumm C; Rivière A; Wilckens C; Löning T
Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):477-84. PubMed ID: 1980167
[TBL] [Abstract][Full Text] [Related]
18. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F
Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.
Comerci JT; Runowicz CD; Flanders KC; De Victoria C; Fields AL; Kadish AS; Goldberg GL
Cancer; 1996 Mar; 77(6):1107-14. PubMed ID: 8635131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
